A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
Clinical trial NCT00587067 · COMPLETED
Trial details
- NCT number
- NCT00587067
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2016-05-19
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.